Shanghai-based biopharmaceutical company EpimAb Biotherapeutics has raised a $74 million Series B round led by SDIC Fund Management and healthcare specialist Sherpa Healthcare Partners.
South China Venture Capital also participated in the funding round, along with investors in the $25 million Series A round such as Oriza Seed Venture Capital, Decheng Capital, and 3E Bioventures Capital....
Legend Capital has absorbed lessons from its corporate sponsor to build a diversified investment business across the US dollar and renminbi spaces. It is now trying to take LP relations to a new level
Cerberus Capital Management has agreed to acquire the operating assets of bankrupt Australian equipment finance specialist Axsesstoday.
Sodexo Ventures, the venture capital arm of French food and facilities management services conglomerate Sodexo, has made its second investment in China, committing an undisclosed amount to technology-enabled catering service Meican.
Global Brain has led a $7.8 million round for Idein, a Japanese technology developer focused on systems for device-level data processing, also known as edge computing.